Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Medgenics Inc (NYSE MKT LLC:MDGN)

7.01
Delayed Data
As of Sep 03
 -0.54 / -7.15%
Today’s Change
3.68
Today|||52-Week Range
9.63
+38.54%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$188.2M

Company Description

Medgenics, Inc. is a medical technology company, which develops protein therapeutics medical therapies. Its TARGT (Transduced Autologous Restorative Gene Therapy) platform is designed to provide sustained protein and peptide therapies to treat a range of chronic diseases and conditions. The Company was founded by Andrew Leonard Pearlman on January 27, 2000 and is headquartered in Wayne, PA.

Contact Information

Medgenics, Inc.
Building 700
Wayne Pennsylvania 19087
P:(610) 254-4201
Investor Relations:
(240) 899-5554

Employees

Shareholders

Individual stakeholders18.27%
Other institutional16.48%
Mutual fund holders10.30%

Top Executives

Michael F. ColaPresident, Chief Executive Officer & Director
John Harold LeamanChief Financial Officer
Nir ShapirSenior Vice President-Research & Development
Garry Arthur NeilChief Scientific Officer
Brian PiperVice President-Finance & Head-Investor Relations